Preliminary Report of Usability Study on BiostealthAI's flagship Touchable® Device and Health Management Platform Shows Promising Results

LONDON, UK— December 1, 2024 — BiostealthAI has released the preliminary findings of its ongoing usability study evaluating the effectiveness of its flagship Touchable® device and health management platform. The study is designed to assess the functionality of the hardware and overall usability of the health management platform among elderly individuals suffering from chronic respiratory conditions such as COPD.

The preliminary report outlines key observations, user feedback, and actionable recommendations for improving the usability of the Touchable® device and health management platform. Among the highlights of the report are:

Remarkable Advantage Over Conventional Monitoring Methods: The study reveals a significant advantage of the Touchable® device over traditional health monitoring devices like pulse oximeters. The volume of measurements collected through the Touchable device is orders of magnitude higher than those captured through traditional spot-checks, showcasing its indispensable value for sedentary individuals, especially those without alternative tools. This singular aspect reinforces the efficacy of Touchable® technology in providing comprehensive, non-invasive health monitoring tailored to each user's lifestyle.


Total number of measurements and the average number of measurements collected per user per day over a 14-day period. Importantly, the measurements are captured passively, without requiring any active participation from the user.

High Levels of User Engagement: Participants in the study demonstrated high levels of engagement with the Touchable® device and health management platform, with the average daily measurements exceeding expectations. This indicates a strong acceptance of the technology among the target demographic.

Positive User Feedback: Quantitative feedback collected through the System Usability Scale (SUS) and The Usefulness, Satisfaction, and Ease of Use Questionnaire demonstrates positive user perceptions of the Touchable® device and its integration with the software platform. The average SUS score from the current cohort is 78.6, surpassing 85% of essential home healthcare devices, and indicating a favourable user experience.


Comparison of usability ratings for some home health care devices in Kortum & Peres (2015) as well as 14 common products described by Kortum & Bangor (2013). Image courtesy Research Collective.

Actionable Recommendations: The report provides actionable recommendations for improving the usability of the Touchable device and health management platform based on user feedback and participant observations from the study. These recommendations will inform future design iterations to enhance user experience further.

"We are encouraged by the preliminary findings of our usability study, which demonstrate the effectiveness and acceptance of our Touchable® device and health management platform among individuals with chronic respiratory conditions," said Israel Gbati, CEO at BiostealthAI. "These results reaffirm our commitment to leveraging technology to empower individuals to monitor their health proactively and improve overall well-being."

The full report of the usability study, including detailed findings and recommendations, is available on the BiostealthAI website upon request. For more information about BiostealthAI and its innovative Touchable technology, please visit www.biostealth.ai.

About BiostealthAI

BiostealthAI was established by innovator Israel Gbati and respiratory health advocate Georgios Papanikolaou, in a bid to monitor health 100% silently and continuously, detecting early symptoms of life-threatening ’silent killers’ as they begin to develop. With the emergence of high-processing-power chips, and advanced miniaturised sensor technology the time has arrived for Touchable® technology to enter our lives. Touchables™ are a new generation of medical-grade, health monitoring objects, seamlessly integrated into everyday living, that perform continuous, non-invasive health monitoring, without the need to wear a device, turn it on, put it to charge, or even think about it.